Hold the BRIC-bats: emerging markets still strong but rethink needed
This article was originally published in Scrip
Don't write that epitaph for the BRIC (Brazil, Russia, India and China) major emerging markets just yet. The fundamental demand drivers in these countries are still strong, say experts, although they caution that maybe the best strategy is to accept volatility and devise "pragmatic, on-the-ground and agile" strategies to capture growth.
You may also be interested in...
Aurobindo and Sandoz mutually terminate their planned $1bn deal, leaving many questions on how both sides will re-orient strategies going forward.
Takeda appoints new country head for India and aims to improve patient access to innovative medicines in the largely out-of-pocket market.
The coronavirus pandemic has thrown up unprecedented challenges for the Indian clinical trials segment, as in other parts of the world. Experts tell Scrip how things are poised in the country including potential impact on some critical milestones, but efforts are underway to tackle the crisis.